What is the recommended dosing for Keflex (cefalexin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin (Keflex) Dosing Recommendations

The standard adult dosage of cephalexin ranges from 1 to 4 g daily in divided doses, with the usual adult dose being 250 mg every 6 hours or 500 mg every 12 hours for most common infections. 1

Adult Dosing

  • For most infections, adults should receive 250 mg every 6 hours (1 g daily) 1
  • For streptococcal pharyngitis, skin and skin structure infections, and uncomplicated cystitis in patients over 15 years of age, 500 mg every 12 hours is recommended 1
  • For more severe infections, the dose may be increased to 500 mg four times daily (2 g daily) 2
  • For skin and soft tissue infections specifically, 500 mg three times daily for 7 days is an effective regimen 2, 3
  • If daily doses greater than 4 g are required, parenteral cephalosporins should be considered 1

Pediatric Dosing

  • The usual recommended daily dosage for pediatric patients is 25 to 50 mg/kg divided into 4 doses 1
  • For streptococcal pharyngitis in patients over 1 year of age and for skin and skin structure infections, the total daily dose may be divided and administered every 12 hours 1
  • For otitis media, clinical studies have shown that a higher dosage of 75 to 100 mg/kg/day in 4 divided doses is required 1
  • In severe infections, the pediatric dosage may be doubled 1

Duration of Therapy

  • For most uncomplicated infections, 7 days of therapy is typically sufficient 2
  • For β-hemolytic streptococcal infections, a therapeutic dosage should be administered for at least 10 days 1
  • For uncomplicated cystitis, therapy should be continued for 7 to 14 days 1
  • If the infection has not improved within 5 days, treatment should be extended or reconsidered 2

Special Considerations

  • Patients with renal impairment (creatinine clearance less than 30 ml/min) require a reduction in cephalexin dosage proportional to the reduced kidney function 4
  • Cephalexin is not effective against MRSA; if MRSA is suspected or confirmed, alternative agents should be considered 2
  • Cephalexin has good activity against staphylococci and streptococci but limited activity against anaerobes 2
  • Recent research suggests that twice-daily dosing (500 mg BID) is as effective as four-times-daily dosing for uncomplicated urinary tract infections, which may improve patient adherence 5

Clinical Pearls

  • Cephalexin is rapidly absorbed in the upper intestine and achieves high urinary concentrations (500-1000 μg/ml) following 250-500 mg oral doses 4
  • For prophylaxis of recurrent urinary tract infections, low-dose therapy (250 mg nightly) has been shown to be effective without promoting antimicrobial resistance 6
  • Cephalexin can be administered in relatively high oral doses without gastrointestinal irritation 4
  • For simple skin abrasions without signs of significant infection, topical antimicrobial agents may be sufficient instead of systemic cephalexin 2

Common Pitfalls

  • Avoid using cephalexin for suspected MRSA infections, as it is not effective against this pathogen 2
  • Do not use cephalexin for the treatment of Lyme disease, as it is ineffective for this condition 3
  • Be cautious in patients with a history of immediate hypersensitivity to penicillin, as there may be cross-reactivity with cephalosporins 7
  • Remember to adjust dosing in patients with significant renal impairment 4

References

Guideline

Cephalexin Dosing for Skin Abrasion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cefalexina Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.